1
|
Augsten LV, Göethel G, Gauer B, Feiffer Charão M, von Poser G, Canto RFS, Arbo MD, Eifler-Lima VL, Garcia SC. Antiproliferative activity and toxicity evaluation of 1,2,3-triazole and 4-methyl coumarin hybrids in the MCF7 breast cancer cell line. RSC Med Chem 2023; 14:869-879. [PMID: 37252094 PMCID: PMC10211326 DOI: 10.1039/d3md00031a] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Accepted: 02/28/2023] [Indexed: 12/31/2023] Open
Abstract
Four coumarin-triazole hybrids were selected from our in house library and screened for cytotoxic activity on A549 (lung cancer), HepG2 (liver cancer), J774A1 (mouse sarcoma macrophage), MCF7 (breast cancer), OVACAR (ovarian cancer), RAW (murine leukaemia macrophage), and SiHa (uterus carcinoma) and their in vitro toxicity was assessed on 3T3 (healthy fibroblasts) cell lines. SwissADME pharmacokinetic prediction was performed. Effects on ROS production, mitochondrial membrane potential, apoptosis/necrosis and DNA damage were evaluated. All of the hybrids have good pharmacokinetic predictions. Each of them showed cytotoxic activity against the MCF7 breast cancer cell line, with IC50 between 2.66 and 10.08 μM, lower than cisplatin (45.33 μM) for the same test. One can observe an order of reactivity from the most potent: LaSOM 186 > LaSOM 190 > LaSOM 185 > LaSOM 180, with a better selectivity index than the reference drug cisplatin and the precursor hymecromone, and caused cell death by apoptosis induction. Two compounds showed antioxidant activity in vitro and three disrupted the mitochondrial membrane potential. None of the hybrids caused genotoxic damage to healthy 3T3 cells. All hybrids showed potential for further optimization, mechanism elucidation, in vivo activity and toxicity tests.
Collapse
Affiliation(s)
- Lucas Volnei Augsten
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul Av. Ipiranga 2752 Laboratório 705 Porto Alegre RS Brazil
| | - Gabriela Göethel
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul Av. Ipiranga 2752 Laboratório 705 Porto Alegre RS Brazil
- Laboratório de Toxicologia (LATOX), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre RS Brazil
| | - Bruna Gauer
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul Av. Ipiranga 2752 Laboratório 705 Porto Alegre RS Brazil
| | - Mariele Feiffer Charão
- Laboratório de Toxicologia (LATOX), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre RS Brazil
| | - Gilsane von Poser
- Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul Avenida Ipiranga 2752 - Santa Cecília CEP 90610-000 Porto Alegre RS Brazil
| | - Romulo F S Canto
- Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) Rua Sarmento Leite, 245 Porto Alegre RS Brazil
| | - Marcelo Dutra Arbo
- Laboratório de Toxicologia (LATOX), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre RS Brazil
| | - Vera Lucia Eifler-Lima
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul Av. Ipiranga 2752 Laboratório 705 Porto Alegre RS Brazil
| | - Solange Cristina Garcia
- Laboratório de Toxicologia (LATOX), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre RS Brazil
| |
Collapse
|
2
|
Soares FGN, Göethel G, Kagami LP, das Neves GM, Sauer E, Birriel E, Varela J, Gonçalves IL, Von Poser G, González M, Kawano DF, Paula FR, de Melo EB, Garcia SC, Cerecetto H, Eifler-Lima VL. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans. BMC Pharmacol Toxicol 2019; 20:76. [PMID: 31852548 PMCID: PMC6921407 DOI: 10.1186/s40360-019-0357-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
BACKGROUND Chagas disease (CD) is a tropical parasitic disease. Although the number of people infected is very high, the only drugs available to treat CD, nifurtimox (Nfx) and benznidazole, are highly toxic, particularly in the chronic stage of the disease. Coumarins are a large class of compounds that display a wide range of interesting biological properties, such as antiparasitic. Hence, the aim of this work is to find a good antitrypanosomal drug with less toxicity. The use of simple organism models has become increasingly attractive for planning and simplifying efficient drug discovery. Within these models, Caenorhabditis elegans has emerged as a convenient and versatile tool with significant advantages for the toxicological potential identification for new compounds. METHODS Trypanocidal activity: Forty-two 4-methylamino-coumarins were assayed against the epimastigote form of Trypanosoma cruzi (Tulahuen 2 strain) by inhibitory concentration 50% (IC50). Toxicity assays: Lethal dose 50% (LD50) and Body Area were determined by Caenorhabditis elegans N2 strain (wild type) after acute exposure. Structure-activity relationship: A classificatory model was built using 3D descriptors. RESULTS Two of these coumarins demonstrated near equipotency to Nifurtimox (IC50 = 5.0 ± 1 μM), with values of: 11 h (LaSOM 266), (IC50 = 6.4 ± 1 μM) and 11 g (LaSOM 231), (IC50 = 8.2 ± 2.3 μM). In C. elegans it was possible to observe that Nfx showed greater toxicity in both the LD50 assay and the evaluation of the development of worms. It is possible to observe that the efficacy between Nfx and the synthesized compounds (11 h and 11 g) are similar. On the other hand, the toxicity of Nfx is approximately three times higher than that of the compounds. Results from the QSAR-3D study indicate that the volume and hydrophobicity of the substituents have a significant impact on the trypanocidal activities for derivatives that cause more than 50% of inhibition. These results show that the C. elegans model is efficient for screening potentially toxic compounds. CONCLUSION Two coumarins (11 h and 11 g) showed activity against T. cruzi epimastigote similar to Nifurtimox, however with lower toxicity in both LD50 and development of C. elegans assays. These two compounds may be a feasible starting point for the development of new trypanocidal drugs.
Collapse
Affiliation(s)
- Fabiana Gomes Nascimento Soares
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Gabriela Göethel
- Laboratório Toxicologia/LATOX, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Luciano Porto Kagami
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Gustavo Machado das Neves
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Elisa Sauer
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Estefania Birriel
- Facultad de Ciencias-Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Javier Varela
- Facultad de Ciencias-Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Itamar Luís Gonçalves
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Gilsane Von Poser
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Mercedes González
- Facultad de Ciencias-Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Daniel Fábio Kawano
- Faculdade de Ciências Farmacêuticas, Universidade Estadual de Campinas, Campinas, SP, Brazil
- Departamento de Química Orgânica, Instituto de Química, Universidade Estadual de Campinas, Campinas, SP, Brazil
| | - Fávero Reisdorfer Paula
- Universidade Estadual do Oeste do Paraná, Centro de Ciências Médicas e Farmacêuticas, Cascavel, PR, Brazil
| | - Eduardo Borges de Melo
- Centro de Ciências Médicas e Farmacêuticas, Universidade Estadual do Oeste do Paraná, Cascavel, PR, Brazil
| | - Solange Cristina Garcia
- Laboratório Toxicologia/LATOX, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Hugo Cerecetto
- Facultad de Ciencias-Facultad de Química, Universidad de la República, Montevideo, Uruguay
| | - Vera Lucia Eifler-Lima
- Laboratório de Síntese Orgânica Medicinal/LaSOM, Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
| |
Collapse
|
3
|
Eroshenko DV, Krainova GF, Konysheva AV, Dmitriev MV, Grishko VV. Synthesis, modification, and cytotoxic evaluation of 2,3-secotriterpenic β-ketoesters. Bioorg Med Chem Lett 2018; 28:3752-3760. [PMID: 30340899 DOI: 10.1016/j.bmcl.2018.10.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Revised: 10/04/2018] [Accepted: 10/10/2018] [Indexed: 10/28/2022]
Abstract
A set of β-ketoesters was synthesized from 2,3-seco-18αH-oleanane and 2,3-secolupane bromomethyl ketones. Additionally, hydroxy derivatives with the A-seco- or five-membered A ring were obtained as a result of the reduction or of alkaline hydrolysis of acetic acid β-ketoesters 4, 9. Cytotoxic screening revealed the compound 4 with marked activity (IC50 3.07-3.61 µM) against the HCT 116, MS, RD TE32 cancer cells. The studies of the cytotoxic mechanism enabled elucidating the fact that treatment of the HCT 116 cells with compound 4 for 18 h leads to induction of apoptosis in a dose-dependent manner. This observation was confirmed by registration of chromatin condensation, by the fluorescence increased during Annexin V-FITC staining, and by appearance of a sub-G0 peak in the cell cycle analysis with DAPI. Compound 4 also inhibited migration of cancer cells in the wound healing assay.
Collapse
Affiliation(s)
- Daria V Eroshenko
- Institute of Technical Chemistry of the Ural Branch of the Russian Academy of Sciences, Perm Federal Scientific Centre, Acad. Korolev St. 3, 614013 Perm, Russia
| | - Gulnaz F Krainova
- Institute of Technical Chemistry of the Ural Branch of the Russian Academy of Sciences, Perm Federal Scientific Centre, Acad. Korolev St. 3, 614013 Perm, Russia
| | - Anastasia V Konysheva
- Institute of Technical Chemistry of the Ural Branch of the Russian Academy of Sciences, Perm Federal Scientific Centre, Acad. Korolev St. 3, 614013 Perm, Russia
| | - Maksim V Dmitriev
- Perm State National Research University, Bukirev St. 15, 614990 Perm, Russia
| | - Victoria V Grishko
- Institute of Technical Chemistry of the Ural Branch of the Russian Academy of Sciences, Perm Federal Scientific Centre, Acad. Korolev St. 3, 614013 Perm, Russia.
| |
Collapse
|
4
|
Abstract
Aim: A series of coumarin derivatives was designed as potential antituberculosis agents. Results: The compounds were screened against active and dormant Mycobacterium tuberculosis (Mtb). Compounds 3k and 3n were found to have the most promising activity against replicating MtbH37Rv exhibiting minimum inhibitory concentration of 4.63 and 9.75 μM respectively. The compounds were also effective against dormant MtbH37Rv exhibiting more potency than the standard drugs, isoniazid and rifampicin. The compounds were found to be non-cytotoxic against human cell lines. Conclusion: This study provides promising antituberculosis agents that are effective against replicating as well as dormant Mtb and can thus act as potential leads for further development.
Collapse
|
5
|
Zhao ZF, Wang K, Guo FF, Lu H. Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules. Med Sci Monit 2017; 23:1156-1164. [PMID: 28260746 PMCID: PMC5352006 DOI: 10.12659/msm.898265] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Background Bladder cancer is a major widespread tumor of the genitourinary tract. Around 30% of patients with superficial cancers develop invasive and metastatic pathology. Material/Methods Some new heterocyclic 4-methyl coumarin derivatives were designed using molecular modeling studies to evaluate their potential against bladder cancer lines T24 and RT-4. The designed compounds that showed good binding affinity to T24 and RT4 were synthesized, with excellent yield. The synthesized compounds after structural evaluation were further evaluated for their antiproliferative activity by cell viability assay, cell cycle analysis, and apoptosis assay. Results The compound BC-14 exhibited the best cytotoxicity against T24 cells, but were not highly active against RT4 cells. Conclusions The results of the present study may suggest the selectivity pattern of the synthesized compounds. These results should be explored further with chemical modification for other cancer types.
Collapse
Affiliation(s)
- Zhi-Feng Zhao
- Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong, China (mainland)
| | - Kai Wang
- Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong, China (mainland)
| | - Feng-Fu Guo
- Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong, China (mainland)
| | - Hua Lu
- Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong, China (mainland)
| |
Collapse
|